Rapid Acting Antidepressants - Advances in Pharmacology
Latest Publications

TOTAL DOCUMENTS

15

(FIVE YEARS 15)

H-INDEX

1

(FIVE YEARS 1)

Published By Elsevier

9780128201893

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Involvement of muscarinic receptor mechanisms in antidepressant drug action

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.03.003 ◽

2020 ◽

pp. 311-356

Author(s):

Jeffrey M. Witkin ◽

Jodi L. Smith ◽

Lalit K. Golani ◽

Emily A. Brooks ◽

Anna E. Martin

Keyword(s):

Muscarinic Receptor ◽

Antidepressant Drug ◽

Download Full-text

mGlu2/3 receptor as a novel target for rapid acting antidepressants

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.04.001 ◽

2020 ◽

pp. 289-309

Author(s):

Shigeyuki Chaki

Keyword(s):

Download Full-text

Clinical overview of NMDA-R antagonists and clinical practice

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.04.004 ◽

2020 ◽

pp. 103-129 ◽

Author(s):

Pasha A. Davoudian ◽

Samuel T. Wilkinson

Keyword(s):

Clinical Practice ◽

Clinical Overview

Download Full-text

Contributors

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/s1054-3589(20)30047-8 ◽

2020 ◽

pp. xi-xiii

Download Full-text

The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.04.002 ◽

2020 ◽

pp. 357-386

Author(s):

Wayne C. Drevets ◽

Anindya Bhattacharya ◽

Maura L. Furey

Keyword(s):

Future Directions ◽

Muscarinic Antagonist ◽

Antidepressant Efficacy

Download Full-text

The role of eEF2 kinase in the rapid antidepressant actions of ketamine

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.04.005 ◽

2020 ◽

pp. 79-99 ◽

Author(s):

Kanzo Suzuki ◽

Lisa M. Monteggia

Keyword(s):

Download Full-text

Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.05.002 ◽

2020 ◽

pp. 237-259 ◽

Author(s):

Jaskaran B. Singh ◽

Maggie Fedgchin ◽

Ella J. Daly ◽

Wayne C. Drevets

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Relapse Prevention ◽

Treatment Resistant ◽

Major Depressive

Download Full-text

Ketamine for depression clinical issues

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.02.005 ◽

2020 ◽

pp. 131-162

Author(s):

Syed Z. Iqbal ◽

Sanjay J. Mathew

Keyword(s):

Clinical Issues

Download Full-text

The emergence of ketamine as a novel treatment for posttraumatic stress disorder

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.05.004 ◽

2020 ◽

pp. 261-286

Author(s):

Adriana Feder ◽

Sarah B. Rutter ◽

Daniela Schiller ◽

Dennis S. Charney

Keyword(s):

Posttraumatic Stress Disorder ◽

Posttraumatic Stress ◽

Stress Disorder ◽

Novel Treatment

Download Full-text

Neurobiological biomarkers of response to ketamine

Rapid Acting Antidepressants - Advances in Pharmacology ◽

10.1016/bs.apha.2020.05.003 ◽

2020 ◽

pp. 195-235

Author(s):

Bashkim Kadriu ◽

Elizabeth D. Ballard ◽

Ioline D. Henter ◽

Stephen Murata ◽

Nimesha Gerlus ◽

...

Download Full-text